Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Diabetes: Daily Aspirin or Other Antiplatelet for Diabetes Patients with Ischemic Vascular Disease (IVD) Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 31 Clinics in the Prevea Health health system


The results below represent the care of 615 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
Prevea Health - Allouez

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Arcadia

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Ashwaubenon
N=107
85.98 %
View Historical Data
Prevea Health - Chippewa Falls

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Cornell

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - East DePere
N=136
86.03 %
View Historical Data
Prevea Health - East Mason
N=103
86.41 %
View Historical Data
Prevea Health - Eau Claire

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Gillett

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Howard
N=167
85.03 %
View Historical Data
Prevea Health - HWC

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Kewaunee

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Lena

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Luxemburg

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Marinette

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Menomonie

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Mountain

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Oconto

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Oconto Falls

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - On-Site Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Osseo

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Plymouth

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Pulaski

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Seymour

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Shawano Avenue

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Sheboygan

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - St. Mary's
N=102
85.29 %
View Historical Data
Prevea Health - St. Vincent

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Vernon Dr.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Washington St.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - West DePere

The number of patients or providers is too small for
purposes of reliably reporting performance

Based on trials involving other secondary prevention therapies, the American College of Cardiology (ACC) and the American Heart Assocation (AHA) recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions. The American Diabetes Association (ADA) supports this recommendation as a secondary prevention strategy for type 1 or type 2 diabetes with a history of cardiovascular disease.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.